Your browser doesn't support javascript.
loading
p19INK4d inhibits proliferation and enhances imatinib efficacy through BCR-ABL signaling pathway in chronic myeloid leukemia.
Kuang, Yijin; Han, Xu; Cao, Pengfei; Xiong, Dehui; Peng, Yuanliang; Liu, Zhaoping; Xu, Zhenru; Liang, Long; Roy, Mridul; Liu, Jing; Nie, Ling; Zhang, Ji.
Affiliation
  • Kuang Y; Molecular Biology Research Center & Center for Medical Genetics, School of Life Sciences, Central South University, Changsha 410078, China; School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou 510515, China.
  • Han X; Molecular Biology Research Center & Center for Medical Genetics, School of Life Sciences, Central South University, Changsha 410078, China.
  • Cao P; Department of Hematology, Xiangya Hospital, Hunan Province Key Laboratory of Basic and Applied Hematology, Central South University, Changsha 410008, China.
  • Xiong D; Molecular Biology Research Center & Center for Medical Genetics, School of Life Sciences, Central South University, Changsha 410078, China.
  • Peng Y; Molecular Biology Research Center & Center for Medical Genetics, School of Life Sciences, Central South University, Changsha 410078, China.
  • Liu Z; Department of Clinical Laboratory, The First Affiliated Hospital of South China University, Hengyang 421000, China.
  • Xu Z; Department of Clinical Laboratory, The First Affiliated Hospital of South China University, Hengyang 421000, China.
  • Liang L; Molecular Biology Research Center & Center for Medical Genetics, School of Life Sciences, Central South University, Changsha 410078, China; Molecular Science and Biomedicine Laboratory, State Key Laboratory for Chemo/Biosensing and Chemometrics, College of Biology, College of Chemistry and Chemi
  • Roy M; Molecular Biology Research Center & Center for Medical Genetics, School of Life Sciences, Central South University, Changsha 410078, China; Molecular Science and Biomedicine Laboratory, State Key Laboratory for Chemo/Biosensing and Chemometrics, College of Biology, College of Chemistry and Chemi
  • Liu J; Molecular Biology Research Center & Center for Medical Genetics, School of Life Sciences, Central South University, Changsha 410078, China; Erythropoiesis Research Center, Central South University, Changsha 410078, China.
  • Nie L; Department of Hematology, Xiangya Hospital, Hunan Province Key Laboratory of Basic and Applied Hematology, Central South University, Changsha 410008, China. Electronic address: nieling404@aliyun.com.
  • Zhang J; Department of Clinical Laboratory, The First Affiliated Hospital of South China University, Hengyang 421000, China. Electronic address: zhang_ji001@hotmail.com.
Blood Cells Mol Dis ; 85: 102477, 2020 11.
Article in En | MEDLINE | ID: mdl-32711219
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Gene Expression Regulation, Leukemic / Fusion Proteins, bcr-abl / Cyclin-Dependent Kinase Inhibitor p19 / Imatinib Mesylate / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: Blood Cells Mol Dis Journal subject: HEMATOLOGIA Year: 2020 Document type: Article Affiliation country: China Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Gene Expression Regulation, Leukemic / Fusion Proteins, bcr-abl / Cyclin-Dependent Kinase Inhibitor p19 / Imatinib Mesylate / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: Blood Cells Mol Dis Journal subject: HEMATOLOGIA Year: 2020 Document type: Article Affiliation country: China Country of publication: United States